Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
6
users have commented on this narrative
48
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Medical Properties Trust
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Global Acute Care And Aging Trends Will Drive Rental Growth
Key Takeaways Exceptional access to global, affordable capital and strong rental growth position the company for accelerated portfolio expansion and margin improvement. Strategic international diversification and industry shifts toward sale-leasebacks support stable, resilient revenue streams and robust long-term cash flow growth.
View narrative
US$6.00
FV
32.5% undervalued
intrinsic discount
4.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Mercury Systems
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Expanding Global Defense Spending Will Advance Secure Embedded Solutions
Key Takeaways Shift to higher-margin, next-generation defense programs and vertical integration could drive accelerated revenue and margin expansion beyond current expectations. Strong cash flow from operational improvements enables investment in innovation, acquisitions, or shareholder returns, supporting sustained outperformance and earnings growth.
View narrative
US$80.00
FV
16.6% undervalued
intrinsic discount
7.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Alignment Healthcare
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Digital Health And Aging Population Will Advance Coordinated Care
Key Takeaways Rapid market share gains and scalable operations, aided by top clinical performance and digital health innovations, will boost long-term revenue and earnings power. Unique holistic care model enhances member retention and satisfaction, driving sustainable revenue growth and improving margins over multiple years.
View narrative
US$23.00
FV
34.6% undervalued
intrinsic discount
34.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
QuidelOrtho
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Expanding Access And Aging Demographics Will Redefine Diagnostics
Key Takeaways Accelerated cost-saving actions and structural expansion in recurring revenues are driving margins and earnings higher than consensus expectations. Unique market positioning and upcoming product launches could enable outsized, sustained revenue growth in underserved and rapidly expanding diagnostic segments.
View narrative
US$60.00
FV
56.8% undervalued
intrinsic discount
3.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
NovoCure
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
TTFields Will Lead Oncological Advancements For Aging Populations
Key Takeaways Strong clinical adoption, regulatory tailwinds, and swift geographic expansion position NovoCure for underestimated market penetration and rapid revenue growth across multiple therapy lines. Operational improvements and device innovation boost patient adherence and margins, supporting a quicker path to profitability and resilience to macroeconomic shifts.
View narrative
US$38.00
FV
69.1% undervalued
intrinsic discount
13.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Twist Bioscience
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Automated DNA Synthesis And AI Will Fuel Secular Growth
Key Takeaways Twist's margin expansion and rapid product innovation are driving accelerating profitability and positioning the company for industry-leading financial performance. Expanding demand for synthetic biology, AI-driven drug discovery, and disruptive new markets sets the stage for resilient, compounding revenue and substantial long-term upside.
View narrative
US$50.00
FV
43.8% undervalued
intrinsic discount
17.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Recursion Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
OS 20 Will Accelerate AI Drug Discovery And Clinical Milestones
Key Takeaways Recursion's advanced AI-driven platforms and proprietary models position it for industry-leading speed, scale, and precision in drug discovery, enabling superior margins and accelerated R&D productivity. Strategic partnerships and innovation cycles establish Recursion as a key player in biopharma pipelines, increasing its attractiveness for major collaborations and potential acquisitions.
View narrative
US$10.00
FV
42.3% undervalued
intrinsic discount
82.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 days ago
author updated this narrative
Diodes
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
AI Demand And Automotive Electrification Will Expand Semiconductor Markets
Key Takeaways Expanding demand in AI, automotive electrification, and digitalization is driving market share gains and long-term growth opportunities for Diodes' products. Strategic product focus and increased manufacturing integration are set to boost margins, reduce costs, and enhance earnings stability over time.
View narrative
US$58.67
FV
10.1% undervalued
intrinsic discount
8.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
4 days ago
author updated this narrative
PAR Technology
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Digital Transformation And AI Will Boost Omnichannel Restaurant Experiences
Key Takeaways PAR's integrated platform and AI-driven features position it to capitalize on industry digital transformation, driving higher margins and capturing larger market share as older systems fade. Rapid growth in multi-product adoption and expansion into new verticals supports accelerated revenue streams and long-term earnings visibility beyond fast food markets.
View narrative
US$97.00
FV
46.5% undervalued
intrinsic discount
13.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies